Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Optimal P2Y12 Inhibitor After Myocardial Infarction: Can Angio-IMR Guide Treatment Selection?

Cardiovascular Drugs and Therapy(2025)10.1007/s10557-025-07745-7Source: DataRank Database

Optimal P2Y12 Inhibitor After Myocardial Infarction: Can Angio-IMR Guide Treatment Selection? is a research paper published in Cardiovascular Drugs and Therapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: bronzeTopics (14)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Leslie Ynalvez,Xander H.T. Wehrens ORCID,Shubh Desai

Live enrichment

PubMed:40591127 OpenAlex:https://openalex.org/W4411917102

Foundation for the National Institutes of Health

Grant: R01HL089598

Foundation for the National Institutes of Health

Grant: R01HL153350

Foundation for the National Institutes of Health

Grant: R01HL160992

National Institutes of Health

Grant: 5R01HL160992-03

Role of Nucleoside-Diphosphate Kinase Signaling in Atrial Fibrillation

National Institutes of Health

Grant: 5R01HL153350-04

Junctophilin-2 cleavage in ischemic heart disease

National Institutes of Health

Grant: 5R01HL089598-09

CaMKII Regulation of Cardiac Ryanodine Receptors in Atrial Fibrillation

FWCI

0.00

Citation Percentile

0.2%

bronzeLicense: Springer Nature TDM

journalhttps://link.springer.com/content/pdf/10.1007/s10557-025-07745-7.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10557-025-07745-7.pdf

publisherhttps://link.springer.com/article/10.1007/s10557-025-07745-7

journalhttps://doi.org/10.1007/s10557-025-07745-7

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40591127

Fields of Study

Acute Myocardial Infarction ResearchCardiovascular Function and Risk FactorsHeart Failure Treatment and Management03 medical and health sciences0302 clinical medicine

Keywords

MedicineP2Y12Selection (genetic algorithm)Myocardial infarctionCardiologyInternal medicineIntensive care medicineClopidogrelArtificial intelligence

Sustainable Development Goals

SDG 0: Zero hunger